BOSTON, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging ...

BOSTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging ...

Otsuka Pharmaceutical is broadening its scope in rare disease, striking a deal to acquire Jnana Therapeutics and its lead drug candidate, a small molecule on track for pivotal testing in a ...

Jnana Therapeutics is hitting early-stage momentum, adding additional validation in the form of new cash and a fresh Big Pharma collaboration just as its lead metabolic disease asset launches into ...

BCU's fourth annual convocation with Governor Thaawarchand Gehlot, Justice P.B. Bajanthri, and Minister M.C. Sudhakar.

Jnana Therapeutics announced Tuesday that it raised $107 million in series C financing, more than doubling the $100 million it raised in its previous two rounds. Jnana also struck its second drug ...

Swiss pharma group Roche has doubled down on a partnership with Jnana Therapeutics, paying $50 million upfront to tap into the Boston-based biotech drug discovery platform for a wide-ranging push ...

Investors are betting that protein science will lead to new lines of attack on disease. Jnana Therapeutics Inc. is launching with $50 million and a plan to discover drugs for cancer and other ...

Like Walgude, hundreds of women in and around Velhe are aware of how low Hb affects their body, thanks to a seven-year-long blood testing campaign conducted by Jnana Prabodhini, an institution ...